FIELD: medicine, hematology. SUBSTANCE: invention proposes blood plasma substituent showing capability to metabolism and containing starch ester of molecular mass (Mw) > 20000 Da and molar substitution 0.1-1.5 as colloidal component. Acetylstarch (Mw - 200000-230000 Da, molar substitution is 0.3-0.5) is used as starch ester. EFFECT: improved property of substituent. 4 cl, 3 dwg
Authors
Dates
1998-05-10—Published
1992-07-09—Filed